Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Mesothelioma, Malignant × nintedanib × Clear all

Phase

Status

Sponsor Class

OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Thyroid Neoplasms 1 Sarcoma 1 Neoplasm Metastasis 1 Mesothelioma, Malignant 1 Endometrial Adenocarcinoma 1 Carcinoma, Medullary 1

Interventions

Cisplatin 4 Pemetrexed 3 Gemcitabine 2 Bortezomib 2 raltitrexed 1 nintedanib 1 ascrinvacumab 1 Radiotherapy 1 Neoadjuvant Therapy 1 Chemotherapy, Adjuvant 1 Cerebral Decortication 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02863055 2025-09-19

NEMO

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated

Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡